1,110
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Zero-contrast imaging for the assessment of transcatheter aortic valve implantation in candidates with renal dysfunction

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2224888 | Received 06 Mar 2023, Accepted 08 Jun 2023, Published online: 23 Jun 2023

References

  • Ng VG, Hahn RT, Nazif TM. Planning for success: pre-procedural evaluation for transcatheter aortic valve replacement. Cardiol Clin. 2020;38(1):1–7. doi: 10.1016/j.ccl.2019.09.013.
  • Ramee S, Anwaruddin S, Kumar G, et al. The rationale for performance of coronary angiography and stenting before transcatheter aortic valve replacement: from the interventional section leadership council of the American college of cardiology. JACC Cardiovasc Interv. 2016;9(23):2371–2375. doi: 10.1016/j.jcin.2016.09.024.
  • Holmes DR, Jr., Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American heart association, American society of echocardiography, european association for Cardio-Thoracic surgery, heart failure society of america, mended hearts, society of cardiovascular anesthesiologists, society of cardiovascular computed tomography, and society for cardiovascular magnetic resonance. Cathet Cardiovasc Intervent. 2012;79(7):1023–1082. doi: 10.1002/ccd.24351.
  • Faillace BLR, Ribeiro HB, Campos CM, et al. Potential of transcatheter aortic valve replacement to improve post-procedure renal function. Cardiovasc Revasc Med. 2017;18(7):507–511. doi: 10.1016/j.carrev.2017.03.031.
  • Nunes Filho ACB, Katz M, Campos CM, et al. Impact of acute kidney injury on short- and long-term outcomes after transcatheter aortic valve implantation. Rev Esp Cardiol. 2019;72(1):21–29. doi: 10.1016/j.rec.2017.11.024.
  • Yamamoto M, Hayashida K, Mouillet G, et al. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;62(10):869–877. doi: 10.1016/j.jacc.2013.04.057.
  • Jackel M, Keller S, Prager EP, et al. The impact of transcatheter aortic valve implantation planning and procedure on acute and chronic renal failure. Cardiol J. 2023;30(2):247–255. doi: 10.5603/CJ.a2021.0057.
  • Jochheim D, Schneider VS, Schwarz F, et al. Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation. Clin Radiol. 2014;69(10):1034–1038. doi: 10.1016/j.crad.2014.05.106.
  • Otto CM, Nishimura RA, Bonow RO, et al. ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology. American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;143(5):e72–e227.
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580.
  • Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5):S45–S60. doi: 10.1093/ejcts/ezs533.
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. doi: 10.1159/000339789.
  • Francone M, Budde RPJ, Bremerich J, et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting-a consensus document by the european society of cardiovascular radiology (ESCR). Eur Radiol. 2020;30(5):2627–2650. doi: 10.1007/s00330-019-06357-8.
  • Wang H, Hanna JM, Ganapathi A, et al. Comparison of aortic annulus size by transesophageal echocardiography and computed tomography angiography with direct surgical measurement. Am J Cardiol. 2015;115(11):1568–1573. doi: 10.1016/j.amjcard.2015.02.060.
  • Husser O, Holzamer A, Resch M, et al. Prosthesis sizing for transcatheter aortic valve implantation–comparison of three dimensional transesophageal echocardiography with multislice computed tomography. Int J Cardiol. 2013;168(4):3431–3438. doi: 10.1016/j.ijcard.2013.04.182.
  • Bernhardt P, Rodewald C, Seeger J, et al. Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol. 2016;105(3):273–278. doi: 10.1007/s00392-015-0920-6.
  • Mayr A, Klug G, Reinstadler SJ, et al. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol. 2018;28(11):4625–4634. doi: 10.1007/s00330-018-5386-2.
  • Gozdek M, Kuzma L, Dabrowski EJ, et al. Outcomes of transcatheter aortic valve implantation comparing medtronic’s evolut PRO and evolut R: a systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2023;20(4):3439.
  • Aregger F, Wenaweser P, Hellige GJ, et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant. 2009;24(7):2175–2179. doi: 10.1093/ndt/gfp036.
  • Allende R, Webb JG, Munoz-Garcia AJ, et al. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. Eur Heart J. 2014;35(38):2685–2696. doi: 10.1093/eurheartj/ehu175.
  • Venturi G, Scarsini R, Pighi M, et al. Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI. Catheter Cardiovasc Interv. 2022;99(6):1925–1934. doi: 10.1002/ccd.30156.
  • Castriota F, Nerla R, Micari A, et al. Contrast-Zero transcatheter aortic valve replacement for patients with severe renal dysfunction: a single-center experience. JACC Cardiovasc Interv. 2018;11(8):820–822. doi: 10.1016/j.jcin.2018.01.280.
  • Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-Art review. J Am Coll Cardiol. 2019;74(3):362–372. doi: 10.1016/j.jacc.2019.06.012.
  • Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65(20):2173–2180. doi: 10.1016/j.jacc.2015.03.034.
  • Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6(6):e005960.
  • Mariani J, Jr., Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (minimizing cOntrast utiliZation with IVUS guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014;7(11):1287–1293. doi: 10.1016/j.jcin.2014.05.024.